Leah Fletcher, the visionary founder and CEO of Monksland-based Dunbar Pharma, has been crowned the Enterprise Ireland High Potential Start-Up (HPSU) Founder of the Year for 2026. The prestigious accolade, awarded at a ceremony held at the Salesforce Tower in Dublin, recognizes Fletcher’s pioneering work in the biotech sector and her leadership in establishing Ireland’s first EU GMP-certified cannabinoid pharmaceutical manufacturing facility.
Dunbar Pharma has gained significant industry attention for the development of WaterClear THC™, a high-purity, plant-derived dronabinol active pharmaceutical ingredient. By blending rigorous pharmaceutical standards with innovative botanical extraction, Fletcher has positioned her company at the forefront of the therapeutic cannabinoid market, setting a new benchmark for excellence in life sciences manufacturing.
Celebrating Entrepreneurial Excellence at the Salesforce Tower
The Founder of the Year Awards are the culmination of the HPSU Founders Forum, a collaborative initiative now in its 11th year. Delivered in partnership with Select Strategies, the program serves as a cornerstone for Ireland’s thriving startup ecosystem, which frequently leverages advanced technological tools—ranging from AI-driven data analytics to cloud-based supply chain management—to scale operations globally.
The event featured a high-stakes pitch session, where finalists presented their growth strategies to a distinguished panel. Moderated by Gary Fox of The Entrepreneur Experiment, the judging panel included Enterprise Ireland’s Donnchadh Cullinan, alongside seasoned entrepreneurs Dan Fox of Johnson Hana and Heidi Davis of Peri. The competition was fierce, with finalists representing a diverse cross-section of Ireland’s innovation economy, including startups operating in sectors like cybersecurity, SaaS, and healthtech.
The Intersection of Biotech and Emerging Technology
As the industry evolves, the boundary between pharmaceutical manufacturing and digital infrastructure continues to blur. Modern biotech firms are increasingly integrating AI and machine learning to accelerate drug discovery and optimize production yields. Dunbar Pharma’s success reflects a broader trend within the Irish startup community, where companies are increasingly utilizing sophisticated data platforms—such as those integrated into the Google Cloud ecosystem—to ensure compliance, manage global logistics, and conduct clinical research.
Mark Christal, executive director at Enterprise Ireland, highlighted the depth of talent emerging from the Founders Forum. “Over the past 11 years, 500 HPSU companies have come through the program,” Christal noted. “That mix reflects the diversity, creativity, and ambition that define Ireland’s entrepreneurial spirit. Tonight’s finalists were chosen by their peers, which speaks volumes about the respect they have earned within this competitive community.”
Scaling for the Future
The HPSU Founders Forum has become a vital engine for growth, fostering a peer-to-peer network that supports founders as they transition from early-stage startups to international market leaders. For Fletcher and Dunbar Pharma, this award serves as a launchpad for the next phase of expansion. As the global demand for standardized cannabinoid medicine grows, the company is well-positioned to leverage its GMP-certified status to secure its place as a key player in the European pharmaceutical supply chain.
By emphasizing both technical rigor and commercial scalability, the 2026 awards have reinforced the importance of the life sciences sector within Ireland’s technology-driven economy. As these companies continue to scale, they are not only contributing to medical advancements but are also embedding themselves into the digital fabric of the global market, utilizing high-tech infrastructure to navigate the complexities of international trade and regulatory compliance.
Fletcher’s win serves as a testament to the resilience and vision required to lead in the highly regulated biotech space, marking an auspicious start to what promises to be a decade of significant growth for Ireland’s most promising startups.
Disclaimer: This content is auto-generated for informational purposes only.
Source: Read Original News
